Many in Need of Substance Use Disorder Treatment Not Receiving It

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 8, 2025.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Jan. 8, 2025 -- A gap persists between the need for and receipt of substance use disorder (SUD) treatment among U.S. individuals, according to a research letter published online Jan. 6 in JAMA Network Open.

Ligang Liu, Pharm.D., from The Ohio State University in Columbus, and colleagues described treatment needs, treatment receipts, perceived needs, and treatment barriers for SUD. The analysis included annual reports for the National Survey on Drug Use and Health (2013 to 2023; 657,583 participants).

The researchers found that the prevalence of individuals needing SUD treatment increased from 8.2 percent in 2013 to 17.1 percent in 2023, with prevalence of alcohol use disorder increasing from 6.6 to 10.2 percent and drug use disorder increasing from 2.6 to 9.6 percent. Opioid use disorder prevalence increased from 0.8 percent in 2016 to 2.0 percent in 2023. However, the percentage of participants receiving treatment decreased, overall, from 9.3 percent in 2013 to 6.5 percent in 2020. There was a rebound in SUD treatment rates to 14.9 percent in 2022, with stabilization thereafter. A similar pattern was seen for alcohol use disorder treatment (6.3 percent in 2013, 4.3 percent in 2020, and 7.6 percent in 2022); drug use disorder treatment (13.4 percent in 2013, 7.1 percent in 2020, and 13.1 percent in 2022); and opioid use disorder treatment (11.2 percent in 2020, 22.1 percent in 2021, and 18.3 percent in 2022). Cited reasons for not receiving treatment included reluctance to stop substance use, insufficient health care coverage, lack of awareness about treatment programs, and negative impacts on employment and community perceptions.

"These results call for urgent interventions to bridge the gap between the need for and receipt of SUD treatment," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords